相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Overcoming drug resistance in pancreatic cancer
Jiang Long et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Akt Requires Glucose Metabolism to Suppress Puma Expression and Prevent Apoptosis of Leukemic T Cells
Jonathan L. Coloff et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Slug inhibition upregulates radiation-induced PUMA activity leading to apoptosis in cholangiocarcinomas
Kejun Zhang et al.
MEDICAL ONCOLOGY (2011)
Downregulation of nuclear factor-κB p65 subunit by small interfering RNA synergizes with gemcitabine to inhibit the growth of pancreatic cancer
Rui Kong et al.
CANCER LETTERS (2010)
Pancreatic Cancer
Manuel Hidalgo
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Curative Radiation Therapy for Pancreatic Malignancies
Ellen W. Cooke et al.
SURGICAL CLINICS OF NORTH AMERICA (2010)
Akt inhibitors induce apoptosis in chronic lymphocytic leukemia cells
Merce de Frias et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Phosphatidylinositol 3-Kinase/AKT Pathway Regulates the Endoplasmic Reticulum to Golgi Traffic of Ceramide in Glioma Cells A LINK BETWEEN LIPID SIGNALING PATHWAYS INVOLVED IN THE CONTROL OF CELL SURVIVAL
Paola Giussani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells
Gary L. Gallia et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells
Kuen-Feng Chen et al.
CANCER RESEARCH (2008)
Nuclear Factor-κB p65/relA Silencing Induces Apoptosis and Increases Gemcitabine Effectiveness in a Subset of Pancreatic Cancer Cells
Xue Pan et al.
CLINICAL CANCER RESEARCH (2008)
Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinoma
Zheng Wang et al.
CLINICAL CANCER RESEARCH (2008)
Metastatic pancreatic cancer 2008: Is the glass less empty?
Jacqueline Nieto et al.
ONCOLOGIST (2008)
Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function
Michael Fraser et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Ad-PUMA sensitizes drug-resistant choriocarcinoma cells to chemotherapeutic agents
Yan Chen et al.
GYNECOLOGIC ONCOLOGY (2007)
Dissociation of gemcitabine sensitivity and protein kinase B signaling in pancreatic ductal adenocarcinoma models
Nhu-An Pham et al.
PANCREAS (2007)
Involvement of up-regulation of PUMA in non-steroidal anti-inflammatory drug-induced apoptosis
Tomoaki Ishihara et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Nuclear factor-κ13 in development, prevention, and therapy of cancer
Carter Van Waes
CLINICAL CANCER RESEARCH (2007)
Beyond I kappa Bs: alternative regulation of NF-kappa B activity
Manfred Neumann et al.
FASEB JOURNAL (2007)
Increased expression of tissue transglutaminase in pancreatic ductal adenocarcinoma and its implications in drug resistance and metastasis
Amit Verma et al.
CANCER RESEARCH (2006)
Role of p53 up-regulated modulator of apoptosis and phosphorylated Akt in melanoma cell growth, apoptosis, and patient survival
Alison M. Karst et al.
CANCER RESEARCH (2006)
The BH3-only protein, PUMA, is involved in oxaliplatin-induced apoptosis in colon cancer cells
Xinyiny Wang et al.
BIOCHEMICAL PHARMACOLOGY (2006)
PUMA sensitizes lung cancer cells to chemotherapeutic agents and irradiation
J Yu et al.
CLINICAL CANCER RESEARCH (2006)
Administration of PUMA adenovirus increases the sensitivity of esophageal cancer cells to anticancer drugs
Haijuan Wang et al.
CANCER BIOLOGY & THERAPY (2006)
Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer
S Banerjee et al.
CANCER RESEARCH (2005)
Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma
S Yamamoto et al.
CLINICAL CANCER RESEARCH (2004)
Role of the phosphatidylinositol 3′-kinase-Akt signal pathway in the proliferation of human pancreatic ductal carcinoma cell lines
A Takeda et al.
PANCREAS (2004)
Inhibition of AKT abrogates chemotherapy-induced NF-κB survival mechanisms:: Implications for therapy in pancreatic cancer
BN Fahy et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2004)
Structure, regulation and function of PKB/AKT - a major therapeutic target
M Hanada et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2004)
siRNA directed against c-Src enhances pancreatic adenocarcinoma cell gemcitabine chemosensitivity
MS Duxbury et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2004)
Inactivation of Akt and NF-kappa B play important roles during indole-3-carbinol-induced apoptosis in breast cancer cells
KW Rahman et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2004)
Targeting the PI3K-Akt pathway in human cancer: Rationale and promise
J Luo et al.
CANCER CELL (2003)
AKT inhibition is associated with chemosensitisation in the pancreatic cancer cell line MIA-PaCa-2
BN Fahy et al.
BRITISH JOURNAL OF CANCER (2003)
Insulin signaling through Akt/protein kinase B analyzed by small interfering RNA-mediated gene silencing
ZY Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Role of NF-κB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death
A Arlt et al.
ONCOGENE (2003)
PUMA mediates the apoptotic response to p53 in colorectal cancer cells
J Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Frequent activation of AKT2 kinase in human pancreatic carcinomas (vol 87, pg 470, 2002)
DA Altomare et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
Activation of the PI3K/Akt pathway and chemotherapeutic resistance
KA West et al.
DRUG RESISTANCE UPDATES (2002)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
Present and future treatment of pancreatic cancer
V Heinemann
SEMINARS IN ONCOLOGY (2002)
The protein kinase B/Akt signalling pathway in human malignancy
KM Nicholson et al.
CELLULAR SIGNALLING (2002)
Ten years of protein kinase B signalling: a hard Akt to follow
DP Brazil et al.
TRENDS IN BIOCHEMICAL SCIENCES (2001)
Blockade of NF-κB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis
SY Huang et al.
ONCOGENE (2001)
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
SM Elbashir et al.
NATURE (2001)
PUMA, a novel proapoptotic gene, is induced by p53
K Nakano et al.
MOLECULAR CELL (2001)